T2 mapping与T2 IDEAL预测甲状腺相关眼病患者静脉糖皮质激素治疗反应
回顾性纳入63例活动期中重度甲状腺相关眼病患者,治疗前行眼眶MRI T2 mapping与T2 IDEAL检查,比较静脉糖皮质激素治疗有效组(35例)与无效组(28例)的基线影像参数,发现眼外肌平均T2弛豫时间与最大水分数为独立预测因子,两者联合预测的曲线下面积为0.844。
要点
- 治疗前眼外肌平均T2弛豫时间与最大水分数是静脉糖皮质激素治疗有效的独立预测因子。
- 眼外肌平均T2弛豫时间≥77.1且最大水分数≥91.52联合预测曲线下面积为0.844,敏感度77.1%。
- 眼外肌最大水分数≥91.52时预测特异度达89.3%。
核心结论
- 基于T2 mapping与T2 IDEAL的眼眶组织治疗前定量测量有助于预测活动期中重度甲状腺相关眼病患者的静脉糖皮质激素治疗反应,眼外肌平均T2弛豫时间与最大水分数可能成为有前景的预测指标。
研究设计与样本
- 回顾性纳入63例活动期中重度甲状腺相关眼病患者,治疗前接受眼眶MRI检查,按静脉糖皮质激素治疗反应分为有效组35例与无效组28例,比较两组基线临床特征与影像参数,采用二元logistic回归确定独立预测因子并以受试者工作特征曲线评估预测效能。
关键影像表现/征象
- 有效组眼外肌平均T2弛豫时间(P=0.001)、眼外肌最大T2弛豫时间(P=0.001)、眼外肌平均水分数(P<0.001)、眼外肌最大水分数(P<0.001)及眼球突出度(P=0.007)均高于无效组。
诊断标准与关键数值
- 多因素分析显示眼外肌平均T2弛豫时间(P<0.001)与眼外肌最大水分数(P<0.001)为治疗有效的独立预测因子。
- 眼外肌平均T2弛豫时间≥77.1且眼外肌最大水分数≥91.52联合预测的曲线下面积为0.844,预测敏感度77.1%。
- 眼外肌最大水分数≥91.52时预测特异度89.3%。
临床应用与阅片要点
- 对活动期中重度甲状腺相关眼病患者,治疗前可测量眼外肌平均T2弛豫时间与最大水分数,两者联合有助于预判静脉糖皮质激素治疗反应。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To investigate the performance of combined T2 mapping and T2 iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL) in orbital tissues to predict the therapeutic efficacy of intravenous glucocorticoids (IVGCs) for active and moderate-to-severe thyroid-associated ophthalmopathy (TAO).
METHOD: Sixty-three active and moderate-to-severe TAO patients (responsive group, n = 35; unresponsive group, n = 28) who underwent orbital MRI before receiving IVGCs were retrospectively enrolled. Baseline clinical characteristics and imaging parameters were analyzed and compared between the two groups of different therapeutic efficacy. Binary logistic regression analysis was conducted to determine the independent predictors, the predictive performance of which was evaluated using receiver operating characteristic curve analysis.
RESULTS: The mean T2 relaxation time of extraocular muscle (EOM-T2RTmean) (P = 0.001), maximum T2RT of EOM (EOM-T2RTmax) (P = 0.001), mean water fraction of EOM (EOM-WFmean) (P < 0.001), maximum WF of EOM (EOM-WFmax) (P < 0.001) and exophthalmos (P = 0.007) were significantly higher in the responsive group than in the unresponsive group. EOM-T2RTmean (P < 0.001) and EOM-WFmax (P < 0.001) were determined as independent predictors for responsive patients with TAO in the multivariable analysis. Combining EOM-T2RTmean ≥ 77.1 and EOM-WFmax ≥ 91.52 demonstrated optimal efficiency for prediction (area under the curve = 0.844) and optimal predictive sensitivity (77.1%). Setting EOM-WFmax ≥ 91.52 achieved the optimal predictive specificity (89.3%).
CONCLUSIONS: Pretherapeutic quantitative measurements, based on combining T2 mapping and T2 IDEAL in orbital tissues, are valuable for predicting IVGC treatment response in active and moderate-to-severe TAO. EOM-T2RTmean and EOM-WFmax may become promising IVGC treatment response predictors.
引用
- Zhai L, Luo B, Wu H, et al. Prediction of treatment response to intravenous glucocorticoid in patients with thyroid-associated ophthalmopathy using T2 mapping and T2 IDEAL. Eur J Radiol. 2021. PMID: 34252869. doi:10.1016/j.ejrad.2021.109839
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。